Correlation Between Verona Pharma and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Novartis AG ADR, you can compare the effects of market volatilities on Verona Pharma and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Novartis.

Diversification Opportunities for Verona Pharma and Novartis

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Verona and Novartis is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Verona Pharma i.e., Verona Pharma and Novartis go up and down completely randomly.

Pair Corralation between Verona Pharma and Novartis

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 2.98 times more return on investment than Novartis. However, Verona Pharma is 2.98 times more volatile than Novartis AG ADR. It trades about 0.25 of its potential returns per unit of risk. Novartis AG ADR is currently generating about -0.24 per unit of risk. If you would invest  2,826  in Verona Pharma PLC on August 26, 2024 and sell it today you would earn a total of  1,055  from holding Verona Pharma PLC or generate 37.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  Novartis AG ADR

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Verona Pharma and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and Novartis

The main advantage of trading using opposite Verona Pharma and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Verona Pharma PLC and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine